CO181 Upadacitinib in Moderate-to-Severe Crohn's Disease (CD): A Systematic Review of Remission Outcomes in Adults With Inadequate Response or Intolerance to Biologic Drugs
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.267
https://www.valueinhealthjournal.com/article/S1098-3015(24)00382-6/fulltext
Section Title :
Section Order :
11623
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00382-6&doi=10.1016/j.jval.2024.03.267